# Octreotide Acetate

NDC: 0641-6178
Generic name: Octreotide Acetate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20050408

FDA application: ANDA076330

## Active ingredients

- OCTREOTIDE ACETATE: 1000 ug/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0641-6178"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6178
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9502860d-0261-4d69-a4be-827a5376d356